Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminomaJ Aparicio, X García del Muro, P Maroto, et al.
Breast Cancer Research and Treatment|October 12, 2012
A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter studyE Alba, J I Chacon, A Lluch, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 14, 2010
Current controversies in the management of breast cancerI Tusquets, L García-Estévez, E Adrover, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancerJ Albanell, A González, M Ruiz-Borrego, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 studyC Pico, M Martin, C Jara, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2018
Outcomes of single versus double hormone receptor-positive breast cancer. A GEICAM/9906 sub-studyJ L Ethier, A Ocaña, A Rodríguez Lescure, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 17, 2018
Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudyA J Templeton, Á Rodríguez-Lescure, A Ruíz, et al.
Breast (Edinburgh, Scotland)|June 13, 2026
Association between antibiotic use and pathologic response to neoadjuvant chemotherapy in breast cancer: a multicentre retrospective cohort studyM Zalabardo, I Fernández, A Girona, et al.
ESMO Open|October 1, 2024
Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES studyÁ Guerrero-Zotano, J M Pérez-García, M Ruiz-Borrego, et al.
European Urology|December 13, 2002
Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG)J R Germà-Lluch, X Garcia del Muro, P Maroto, et al.
Pageof 17